Moreland Mary K
- Shares
- 17.16K
- % company
- <0.01%
- Price
- $94.41
- Value
- $1,619,981
Filed Apr 28, 2026
Recent
quick returnPopular searches
live pathsNYSE · Technology · Holders
Recent insider purchases and sales for ABT from Form 4 filings. Institutional holdings surface here when ownership sources publish.
Section freshness
Price Jun 26, 4:03 PM EDT · Statements Mar 30, 8:00 PM EDT
Prices update fastest. Fundamentals, analyst data, and news update on their own schedules, so check these timestamps before comparing signals.
Price time means the latest available trade or regular-market close. Other times show when that section was checked or published.
Ownership read
8 sales and 5 purchases appear in the recent Form 4 filings. Use the filters below to separate real buying and selling from option exercises, gifts, awards, and tax withholding.
Insider flow
ABT
Directional bars ignore awards, gifts, conversions, and tax withholding rows.
Top holder
—
Institutional data pending
Insider stance
Mixed, buy-heavy
$60.44M sold / $2.11B bought
Latest filing
Apr 28, 2026
Most recent holder or insider filing date
Filings shown
84
0 holder / 84 insider
Recent insider transactions
Action codes are translated so open-market buys and sales are separate from awards, gifts, conversions, and tax withholding.
Moreland Mary K
Filed Apr 28, 2026
STARKS DANIEL J
Filed Apr 27, 2026
Ahuja Nita
Filed Apr 24, 2026
Gonzalez Patricia Paola
Filed Apr 24, 2026
STARKS DANIEL J
Filed Apr 24, 2026
STARKS DANIEL J
Filed Apr 24, 2026
McDew Darren W
Filed Apr 24, 2026
Babineaux-Fontenot Claire
Filed Apr 24, 2026
Kumbier Michelle
Filed Apr 24, 2026
Roman Michael F
Filed Apr 24, 2026
Blount Sally E.
Filed Apr 24, 2026
O'Grady Michael
Filed Apr 24, 2026
O'Grady Michael
Filed Apr 24, 2026
Stratton John G
Filed Apr 24, 2026
Conroy Kevin T
Filed Apr 24, 2026
McKinstry Nancy
Filed Apr 24, 2026
McKinstry Nancy
Filed Apr 24, 2026
Boudreau Philip P
Filed Apr 23, 2026
Boudreau Philip P
Filed Apr 23, 2026
Ahuja Nita
Filed Mar 31, 2026
Gonzalez Patricia Paola
Filed Mar 31, 2026
Roman Michael F
Filed Mar 31, 2026
Alpern Robert J
Filed Mar 31, 2026
Stratton John G
Filed Mar 31, 2026
ORVILLE JACOB A
Filed Mar 23, 2026
Cushman Elizabeth C.
Filed Mar 2, 2026
Shroff Eric
Filed Mar 2, 2026
Morrone Louis H.
Filed Mar 2, 2026
Moreland Mary K
Filed Mar 2, 2026
MCCOY JOHN A. JR.
Filed Mar 2, 2026
Salvadori Daniel Gesua Sive
Filed Mar 2, 2026
Cushman Elizabeth C.
Filed Feb 27, 2026
Shroff Eric
Filed Feb 27, 2026
Morrone Louis H.
Filed Feb 27, 2026
Boudreau Philip P
Filed Feb 27, 2026
Moreland Mary K
Filed Feb 27, 2026
Scoggins Christopher J
Filed Feb 27, 2026
MCCOY JOHN A. JR.
Filed Feb 27, 2026
Salvadori Daniel Gesua Sive
Filed Feb 27, 2026
Ford Robert B
Filed Feb 27, 2026
Earnhardt Lisa D
Filed Feb 27, 2026
Boudreau Philip P
Filed Feb 24, 2026
Boudreau Philip P
Filed Feb 24, 2026
Cushman Elizabeth C.
Filed Feb 24, 2026
Cushman Elizabeth C.
Filed Feb 24, 2026
Shroff Eric
Filed Feb 24, 2026
Shroff Eric
Filed Feb 24, 2026
Morrone Louis H.
Filed Feb 24, 2026
Morrone Louis H.
Filed Feb 24, 2026
Moreland Mary K
Filed Feb 24, 2026
Moreland Mary K
Filed Feb 24, 2026
Scoggins Christopher J
Filed Feb 24, 2026
| # | Insider | % company | Action | Shares | Price | Value | Filing date |
|---|---|---|---|---|---|---|---|
| 1 | Moreland Mary K | <0.01% | IProvider-supplied Form 4 action code. Review the original filing before making a trading judgment. | 17.16K | $94.41 | $1,619,981 | Apr 28, 2026 |
| 2 | STARKS DANIEL J | 0.39% | PurchaseOpen-market or direct purchase reported on Form 4. | 6.75M | $92.65 | $625,514,672 | Apr 27, 2026 |
| 3 | Ahuja Nita | <0.01% | Award / grantAward, grant, or acquisition under an equity compensation plan. | 2.29K | No cash value | No cash value | Apr 24, 2026 |
| 4 | Gonzalez Patricia Paola | <0.01% | Award / grantAward, grant, or acquisition under an equity compensation plan. | 9.21K | No cash value | No cash value | Apr 24, 2026 |
| 5 | STARKS DANIEL J | <0.01% | Award / grantAward, grant, or acquisition under an equity compensation plan. | 7.11K | No cash value | No cash value | Apr 24, 2026 |
| 6 | STARKS DANIEL J | 0.39% | Award / grantAward, grant, or acquisition under an equity compensation plan. | 6.74M | No cash value | No cash value | Apr 24, 2026 |
| 7 | McDew Darren W | <0.01% | Award / grantAward, grant, or acquisition under an equity compensation plan. | 12.68K | No cash value | No cash value | Apr 24, 2026 |
| 8 | Babineaux-Fontenot Claire | <0.01% | Award / grantAward, grant, or acquisition under an equity compensation plan. | 7.60K | No cash value | No cash value | Apr 24, 2026 |
| 9 | Kumbier Michelle | <0.01% | Award / grantAward, grant, or acquisition under an equity compensation plan. | 18.00K | No cash value | No cash value | Apr 24, 2026 |
| 10 | Roman Michael F | <0.01% | Award / grantAward, grant, or acquisition under an equity compensation plan. | 10.76K | No cash value | No cash value | Apr 24, 2026 |
| 11 | Blount Sally E. | <0.01% | Award / grantAward, grant, or acquisition under an equity compensation plan. | 36.34K | No cash value | No cash value | Apr 24, 2026 |
| 12 | O'Grady Michael | <0.01% | Award / grantAward, grant, or acquisition under an equity compensation plan. | 5.93K | No cash value | No cash value | Apr 24, 2026 |
| 13 | O'Grady Michael | <0.01% | Award / grantAward, grant, or acquisition under an equity compensation plan. | 7.60K | No cash value | No cash value | Apr 24, 2026 |
| 14 | Stratton John G | <0.01% | Award / grantAward, grant, or acquisition under an equity compensation plan. | 21.32K | No cash value | No cash value | Apr 24, 2026 |
| 15 | Conroy Kevin T | <0.01% | Award / grantAward, grant, or acquisition under an equity compensation plan. | 133.74K | No cash value | No cash value | Apr 24, 2026 |
| 16 | McKinstry Nancy | <0.01% | Award / grantAward, grant, or acquisition under an equity compensation plan. | 2.31K | No cash value | No cash value | Apr 24, 2026 |
| 17 | McKinstry Nancy | <0.01% | Award / grantAward, grant, or acquisition under an equity compensation plan. | 41.01K | No cash value | No cash value | Apr 24, 2026 |
| 18 | Boudreau Philip P | <0.01% | PurchaseOpen-market or direct purchase reported on Form 4. | 2.20K | $91.50 | $201,300 | Apr 23, 2026 |
| 19 | Boudreau Philip P | <0.01% | IProvider-supplied Form 4 action code. Review the original filing before making a trading judgment. | 9.28K | $92.04 | $853,763 | Apr 23, 2026 |
| 20 | Ahuja Nita | <0.01% | Award / grantAward, grant, or acquisition under an equity compensation plan. | 102 | $102.67 | $10,472 | Mar 31, 2026 |
| 21 | Gonzalez Patricia Paola | <0.01% | Award / grantAward, grant, or acquisition under an equity compensation plan. | 5.56K | $102.67 | $570,640 | Mar 31, 2026 |
| 22 | Roman Michael F | <0.01% | Award / grantAward, grant, or acquisition under an equity compensation plan. | 6.28K | $102.67 | $645,076 | Mar 31, 2026 |
| 23 | Alpern Robert J | <0.01% | Award / grantAward, grant, or acquisition under an equity compensation plan. | 10.54K | $102.67 | $1,082,552 | Mar 31, 2026 |
| 24 | Stratton John G | <0.01% | Award / grantAward, grant, or acquisition under an equity compensation plan. | 13.49K | $102.67 | $1,384,916 | Mar 31, 2026 |
| 25 | ORVILLE JACOB A | <0.01% | Award / grantAward, grant, or acquisition under an equity compensation plan. | 50.49K | No cash value | No cash value | Mar 23, 2026 |
| 26 | Cushman Elizabeth C. | <0.01% | SaleOpen-market or direct sale reported on Form 4. | 38.57K | $115.58 | $4,458,267 | Mar 2, 2026 |
| 27 | Shroff Eric | <0.01% | SaleOpen-market or direct sale reported on Form 4. | 39.16K | $115.58 | $4,526,575 | Mar 2, 2026 |
| 28 | Morrone Louis H. | <0.01% | SaleOpen-market or direct sale reported on Form 4. | 76.84K | $115.58 | $8,881,514 | Mar 2, 2026 |
| 29 | Moreland Mary K | <0.01% | SaleOpen-market or direct sale reported on Form 4. | 104.29K | $115.58 | $12,053,954 | Mar 2, 2026 |
| 30 | MCCOY JOHN A. JR. | <0.01% | SaleOpen-market or direct sale reported on Form 4. | 24.63K | $115.58 | $2,846,504 | Mar 2, 2026 |
| 31 | Salvadori Daniel Gesua Sive | <0.01% | SaleOpen-market or direct sale reported on Form 4. | 146.38K | $115.58 | $16,918,254 | Mar 2, 2026 |
| 32 | Cushman Elizabeth C. | <0.01% | Tax withholdingShares withheld to cover tax obligations. Usually administrative, not an open-market sale. | 38.84K | $116.26 | $4,515,073 | Feb 27, 2026 |
| 33 | Shroff Eric | <0.01% | Tax withholdingShares withheld to cover tax obligations. Usually administrative, not an open-market sale. | 39.87K | $116.26 | $4,635,635 | Feb 27, 2026 |
| 34 | Morrone Louis H. | <0.01% | Tax withholdingShares withheld to cover tax obligations. Usually administrative, not an open-market sale. | 77.99K | $116.26 | $9,066,769 | Feb 27, 2026 |
| 35 | Boudreau Philip P | <0.01% | Tax withholdingShares withheld to cover tax obligations. Usually administrative, not an open-market sale. | 71.17K | $116.26 | $8,274,457 | Feb 27, 2026 |
| 36 | Moreland Mary K | <0.01% | Tax withholdingShares withheld to cover tax obligations. Usually administrative, not an open-market sale. | 104.90K | $116.26 | $12,196,139 | Feb 27, 2026 |
| 37 | Scoggins Christopher J | <0.01% | Tax withholdingShares withheld to cover tax obligations. Usually administrative, not an open-market sale. | 77.13K | $116.26 | $8,966,669 | Feb 27, 2026 |
| 38 | MCCOY JOHN A. JR. | <0.01% | Tax withholdingShares withheld to cover tax obligations. Usually administrative, not an open-market sale. | 25.21K | $116.26 | $2,931,263 | Feb 27, 2026 |
| 39 | Salvadori Daniel Gesua Sive | <0.01% | Tax withholdingShares withheld to cover tax obligations. Usually administrative, not an open-market sale. | 147.26K | $116.26 | $17,120,680 | Feb 27, 2026 |
| 40 | Ford Robert B | 0.02% | Tax withholdingShares withheld to cover tax obligations. Usually administrative, not an open-market sale. | 306.46K | $116.26 | $35,629,156 | Feb 27, 2026 |
| 41 | Earnhardt Lisa D | <0.01% | Tax withholdingShares withheld to cover tax obligations. Usually administrative, not an open-market sale. | 90.41K | $116.26 | $10,510,718 | Feb 27, 2026 |
| 42 | Boudreau Philip P | <0.01% | Award / grantAward, grant, or acquisition under an equity compensation plan. | 115.41K | No cash value | No cash value | Feb 24, 2026 |
| 43 | Boudreau Philip P | <0.01% | Award / grantAward, grant, or acquisition under an equity compensation plan. | 78.61K | No cash value | No cash value | Feb 24, 2026 |
| 44 | Cushman Elizabeth C. | <0.01% | Award / grantAward, grant, or acquisition under an equity compensation plan. | 61.96K | No cash value | No cash value | Feb 24, 2026 |
| 45 | Cushman Elizabeth C. | <0.01% | Award / grantAward, grant, or acquisition under an equity compensation plan. | 40.26K | No cash value | No cash value | Feb 24, 2026 |
| 46 | Shroff Eric | <0.01% | Award / grantAward, grant, or acquisition under an equity compensation plan. | 44.82K | No cash value | No cash value | Feb 24, 2026 |
| 47 | Shroff Eric | <0.01% | Award / grantAward, grant, or acquisition under an equity compensation plan. | 41.26K | No cash value | No cash value | Feb 24, 2026 |
| 48 | Morrone Louis H. | <0.01% | Award / grantAward, grant, or acquisition under an equity compensation plan. | 63.56K | No cash value | No cash value | Feb 24, 2026 |
| 49 | Morrone Louis H. | <0.01% | Award / grantAward, grant, or acquisition under an equity compensation plan. | 82.03K | No cash value | No cash value | Feb 24, 2026 |
| 50 | Moreland Mary K | <0.01% | Award / grantAward, grant, or acquisition under an equity compensation plan. | 57.51K | No cash value | No cash value | Feb 24, 2026 |
| 51 | Moreland Mary K | <0.01% | Award / grantAward, grant, or acquisition under an equity compensation plan. | 109.53K | No cash value | No cash value | Feb 24, 2026 |
| 52 | Scoggins Christopher J | <0.01% | Award / grantAward, grant, or acquisition under an equity compensation plan. | 76.27K | No cash value | No cash value | Feb 24, 2026 |
Frequently asked
Abbott Laboratories (ABT) institutional holders are ranked by reported share count when ownership data publishes filing rows.
Abbott Laboratories (ABT) institutional ownership appears when filing-based market data returns holder rows. TECHi does not fill unavailable ownership fields with placeholder shareholders.
Abbott Laboratories (ABT) has 84 Form 4 insider transactions on file, most recently on Apr 28, 2026, separated into purchases, sales, option exercises, awards, gifts, and tax withholding so administrative transactions are distinguished from open-market trades.
Recent ABT insider activity reads Mixed, buy-heavy: 8 sales and 5 purchases. Awards, gifts, conversions, and tax withholding are listed separately because they do not carry the same signal as open-market trades.
STARKS DANIEL J is the most active ABT insider by absolute share movement, with 26.97 million shares moving across the filing history. Review the action labels before treating that activity as buying or selling.